91视频

?
?
?
Home Tags Posts tagged with "Medical devices"

Tag: Medical devices

Baker McKenzie steers Mitsui Chemicals’ USD900m acquisition

Baker McKenzie (Gaikokuho Joint Enterprise) has advised Tokyo-headquartered Mitsui Chemicals on its USD900 million acquisition of US-based Ultradent Products

Regulatory and investigations partner rejoins Kirkland

Kirkland & Ellis has hired Jenny Li as a partner in its government, regulatory and internal investigations practice in Shanghai

Opportunities in Japan’s regenerative medicine, gene therapy markets

By Dio Inoue and Yuka Daimon, Atsumi & Sakai

Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations

Duo advises on Esco’s investment in Allwin Medical Devices

IndusLaw advised Esco Technologies on a strategic investment in Allwin Medical Devices

Strategies for South Korean investment in India

By Suneeth Katarki, Rashi Saraf and Swathi Sreenath, IndusLaw

This article focuses on structuring foreign investment and offers further insights into the dynamics of South Korean investment, with special emphasis on the policy and regulatory framework

Taiwan’s top 100 lawyers 2023

Following an extensive nomination process, Asia Business Law Journal unveils the top performers of Taiwan’s legal profession

Avoiding traps in unlawful medical cosmetology services

By Xue Zheng and Cao Hui, DOCVIT Law Firm

Evolution and practice of MAH system for medical devices

By Ji Fei and Xue Gang, Merits & Tree Law Offices

MOST READ ON LAW.ASIA

Navigating phased-in ESG reporting

Green: Seen it or mean it?

As mandatory ESG reporting is phased in, green claims may face securities law and cross-border compliance scrutiny. General counsel and environmental lawyers assess the evolving challenges

Traditional opera lineage's IP protection

IP protection in traditional opera lineage

By Jiang Shen and Zhao Yao, Jingtian & Gongcheng

Correspondents

AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners
SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners

Follow us on LinkedIn